Abo Bibliothek: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 1045-4403

ISSN Online: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Prostate Cancer and Parasitism of the Bone Hematopoietic Stem Cell Niche

Volumen 22, Ausgabe 2, 2012, pp. 131-148
DOI: 10.1615/CritRevEukarGeneExpr.v22.i2.50
Get accessGet access

ABSTRAKT

A subpopulation of men that appear cured of prostate cancer (PCa) develop bone metastases many years after prostatectomy. This observation indicates that PCa cells were present outside of the prostate at the time of prostatectomy and remained dormant. Several lines of evidence indicate that there are disseminated tumor cells (DTCs) in the bone marrow at the time of prostatectomy. DTCs parasitize the bone microenvironment, where they derive support and impact the microenvironment itself. These DTCs appear to be a heterogeneous population of PCa cells; however, some of them appear to have some aspects of a cancer stem cell (CSC) phenotype as they can develop into clinically detectable metastases. The concept of CSC is controversial; however, several markers of CSC have been identified for PCa, which may represent cells of either basal or luminal origin. These DTCs have now been shown to compete for the hematopoietic stem cell niche in bone, where they may be placed in a dormant state. Interaction with a variety of host factors, including cytokine and cells, may impact the metastatic development and progression, including the dormant state. For example, myeloid cells have been shown to impact both the premetastatic niche and established tumors. Understanding the concepts of how PCa successfully parasitizes the bone microenvironment is paramount toward identifying therapeutic candidates to prevent or diminish PCa bone metastases.

REFERENZIERT VON
  1. Chang L, Graham P H, Hao J, Ni J, Bucci J, Cozzi P J, Kearsley J H, Li Y, Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance, Cell Death & Disease, 4, 10, 2013. Crossref

  2. Nawroth R., Weckermann D., Retz M., Prostata- und Harnblasenkarzinom, Der Urologe, 53, 4, 2014. Crossref

  3. Wang Ning, Docherty Freyja E, Brown Hannah K, Reeves Kimberley J, Fowles Anne CM, Ottewell Penelope D, Dear T Neil, Holen Ingunn, Croucher Peter I, Eaton Colby L, Prostate Cancer Cells Preferentially Home to Osteoblast-rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models, Journal of Bone and Mineral Research, 29, 12, 2014. Crossref

  4. Cook Leah M., Shay Gemma, Aruajo Arturo, Lynch Conor C., Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases, Cancer and Metastasis Reviews, 33, 2-3, 2014. Crossref

  5. Hofbauer Lorenz C, Rachner Tilman D, Coleman Robert E, Jakob Franz, Endocrine aspects of bone metastases, The Lancet Diabetes & Endocrinology, 2, 6, 2014. Crossref

  6. Gernone Angela, Bordonaro Sebastiano, Tralongo Paolo, Optimal sequence of bone target drugs in metastatic prostatic cancer, Expert Review of Anticancer Therapy, 15, 8, 2015. Crossref

  7. Reagan Michaela R., Rosen Clifford J., Navigating the bone marrow niche: translational insights and cancer-driven dysfunction, Nature Reviews Rheumatology, 12, 3, 2016. Crossref

  8. Morhayim Jess, van de Peppel Jeroen, Braakman Eric, Rombouts Elwin W. J. C., ter Borg Mariette N. D., Dudakovic Amel, Chiba Hideki, van der Eerden Bram C. J., Raaijmakers Marc H., van Wijnen Andre J., Cornelissen Jan J., van Leeuwen Johannes P., Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells, Scientific Reports, 6, 1, 2016. Crossref

  9. Taichman Russell S., Patel Lalit R., Bedenis Rachel, Wang Jingcheng, Weidner Savannah, Schumann Taibriana, Yumoto Kenji, Berry Janice E., Shiozawa Yusuke, Pienta Kenneth J., Tang Dean G., GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation, PLoS ONE, 8, 4, 2013. Crossref

  10. CIFUENTES FEDERICO F., VALENZUELA RODRIGO H., CONTRERAS HÉCTOR R., CASTELLÓN ENRIQUE A., Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer, Oncology Reports, 34, 6, 2015. Crossref

  11. Vignani Francesca, Bertaglia Valentina, Buttigliero Consuelo, Tucci Marcello, Scagliotti Giorgio V., Di Maio Massimo, Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer, Cancer Treatment Reviews, 44, 2016. Crossref

  12. Jaworska Dagmara, Król Wojciech, Szliszka Ewelina, Prostate Cancer Stem Cells: Research Advances, International Journal of Molecular Sciences, 16, 11, 2015. Crossref

  13. van der Horst Geertje, van der Mark Maaike, Cheung Henry, van der Pluijm Gabri, Transplantable Animal Studies and Whole-Body Optical Imaging in Prostate Carcinoma, in Prostate Cancer, 1786, 2018. Crossref

  14. Tivari Samir, Lu Haiyan, Dasgupta Tanya, De Lorenzo Mariana S., Wieder Robert, Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence, Cell Communication and Signaling, 16, 1, 2018. Crossref

  15. Sampayo Rocío G., Bissell Mina J., , 144, 2019. Crossref

  16. Rhoades (Sterling) Julie A., Johnson Rachelle W., Lynch Conor C., Localized osteolysis, in Principles of Bone Biology, 2020. Crossref

  17. Herrmann Marietta, Jakob Franz, Bone Marrow Niches for Skeletal Progenitor Cells and their Inhabitants in Health and Disease, Current Stem Cell Research & Therapy, 14, 4, 2019. Crossref

  18. Cursano M.C., Iuliani M., Casadei C., Stellato M., Tonini G., Paganelli G., Santini D., De Giorgi U., Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review, Critical Reviews in Oncology/Hematology, 146, 2020. Crossref

  19. Li Feng, Glinskii Olga V., Mooney Brian P., Rittenhouse-Olson Kate, Pienta Kenneth J., Glinsky Vladislav V., Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype, Oncotarget, 8, 58, 2017. Crossref

  20. Costanzo-Garvey Diane L., Keeley Tyler, Case Adam J., Watson Gabrielle F., Alsamraae Massar, Yu Yangsheng, Su Kaihong, Heim Cortney E., Kielian Tammy, Morrissey Colm, Frieling Jeremy S., Cook Leah M., Neutrophils are mediators of metastatic prostate cancer progression in bone, Cancer Immunology, Immunotherapy, 69, 6, 2020. Crossref

  21. San Martin Rebeca, Pathak Ravi, Jain Antrix, Jung Sung Yun, Hilsenbeck Susan G., Piña-Barba María C., Sikora Andrew G., Pienta Kenneth J., Rowley David R., Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment, Cancer Research, 77, 21, 2017. Crossref

Zukünftige Artikel

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain